LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β‐catenin/cyclin D1 signaling via PLAGL2

MicroRNA-214-3p targets the PLAGL2-MYH9 axis to suppress tumor proliferation and metastasis in human colorectal cancer

(2020) Zili Zhou et al.   Aging-US

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo

(2020) Kimberley C. Clark et al.   Cancers

Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer

(2019) Tong Liu et al.   Molecular Cancer

MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4

(2019) Hongkun Wu et al.   Autophagy

MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1

(2019) Junyong Zhao et al.   BIOMEDICINE & PHARMACOTHERAPY

SALL4 promotes the tumorigenicity of cervical cancer cells through activation of Wnt/β‐catenin pathway via CTNNB1

(2019) Mei Chen et al.   CANCER SCIENCE

LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p

(2019) Lihong Wang et al.   Cancer Medicine

Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma

(2019) Giada Juli et al.   Cancers

The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation

(2019) Ding-wen Cao et al.   ACTA PHARMACOLOGICA SINICA

Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling

(2019) Nidhi Gupta et al.   RNA Biology

Long non‑coding RNA HCP5 promotes prostate cancer cell proliferation by acting as the sponge of miR‑4656 to modulate CEMIP expression

(2019) Renguang Hu et al.   ONCOLOGY REPORTS

Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF

(2019) Yunfei Liu et al.   OncoTargets and Therapy

MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma

(2018) Shan Dang et al.   BIOMEDICINE & PHARMACOTHERAPY

OUP accepted manuscript

(2018)   BRAIN

MicroRNA

(2018) Thomas X. Lu et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential

(2018) Ingrid Spaan et al.   Journal of Hematology & Oncology

MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer

(2018) Bin Xu et al.   PATHOLOGY RESEARCH AND PRACTICE

Advancements in Nanomedicine for Multiple Myeloma

(2018) Alexandre Detappe et al.   TRENDS IN MOLECULAR MEDICINE

LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge

(2018) Leilei Liang et al.   Cell Death & Disease

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway

(2018) Chao Fu et al.   Neurotherapeutics

DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis

(2018) Jing Zhou et al.   Cell Death & Disease

Fibulin-2 is required for basement membrane integrity of mammary epithelium

(2018) Ayman M. Ibrahim et al.   Scientific Reports

Multiple Myeloma 1 Transcription Factor Is Superior to CD138 as a Marker of Plasma Cells in Endometrium

(2018) Robyn N. Parks et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215

(2018) Xiaoli Kong et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer

(2018) Nanpeng Li et al.   ONCOLOGY REPORTS

Targeting noncoding RNAs in disease

(2017) Brian D. Adams et al.   JOURNAL OF CLINICAL INVESTIGATION

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

(2017) C Pawlyn et al.   Blood Cancer Journal

LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression

(2017) Yueli Gu et al.   Oncotarget

Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation

(2016) Nicola Amodio et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

(2015) J Laubach et al.   LEUKEMIA

Correlation between microRNA-21 and sprouty homolog 2 gene expression in multiple myeloma

(2015) JIN-HANG WANG et al.   Molecular Medicine Reports

miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma

(2014) XIAOLING SHE et al.   ONCOLOGY REPORTS

EphrinB-mediated reverse signalling controls junctional integrity and pro-inflammatory differentiation of endothelial cells

(2014) Hui Liu et al.   THROMBOSIS AND HAEMOSTASIS

Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth

(2013) E. Leone et al.   CLINICAL CANCER RESEARCH

Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

(2012) M. Cea et al.   BLOOD

Targeting microRNAs in cancer: rationale, strategies and challenges

(2010) Ramiro Garzon et al.   NATURE REVIEWS DRUG DISCOVERY

WDTC1, the Ortholog of DrosophilaAdiposeGene, Associates With Human Obesity, Modulated by MUFA Intake

(2009) Chao-Qiang Lai et al.   Obesity

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

(2008) G. J. Weiss et al.   ANNALS OF ONCOLOGY

MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a

(2008) Yu Zhang et al.   JOURNAL OF MOLECULAR MEDICINE-JMM